GRIFONI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 2.528
EU - Europa 1.259
AS - Asia 274
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.067
Nazione #
US - Stati Uniti d'America 2.521
PL - Polonia 500
IE - Irlanda 215
IT - Italia 173
SE - Svezia 161
HK - Hong Kong 104
DE - Germania 103
CN - Cina 83
FI - Finlandia 40
SG - Singapore 36
GB - Regno Unito 28
JO - Giordania 18
VN - Vietnam 16
ES - Italia 15
TR - Turchia 8
CA - Canada 7
RU - Federazione Russa 6
BE - Belgio 5
IN - India 5
EG - Egitto 4
UA - Ucraina 4
CH - Svizzera 3
KR - Corea 3
NL - Olanda 3
RO - Romania 2
AP - ???statistics.table.value.countryCode.AP??? 1
EU - Europa 1
FR - Francia 1
JP - Giappone 1
Totale 4.067
Città #
Warsaw 500
Fairfield 466
Ashburn 239
Woodbridge 219
Dublin 215
Chandler 203
Seattle 191
Cambridge 185
Wilmington 163
Houston 160
Ann Arbor 80
Lawrence 76
Princeton 72
Altamura 71
Hong Kong 54
Beijing 51
Buffalo 51
Medford 42
Florence 41
Singapore 26
San Diego 25
Boston 20
Jacksonville 17
Kent 15
Barcelona 14
Falls Church 14
Shanghai 14
Dong Ket 10
New York 10
Boardman 8
Izmir 6
London 6
Moscow 6
Nürnberg 6
Brussels 5
Norwalk 5
Phoenix 5
Toronto 5
Cagliari 4
Cairo 4
Castelliri 4
Milan 4
Pune 4
Redmond 4
Andover 3
Bern 3
Dearborn 3
Düsseldorf 3
Guangzhou 3
Nanjing 3
Redwood City 3
Seoul 3
Bari 2
Chicago 2
Hillsboro 2
Hounslow 2
Kilburn 2
Nanchang 2
Scandicci 2
Siena 2
Velletri 2
Bolano 1
Brampton 1
Bremen 1
Caraglio 1
Castelnuovo 1
Cinisello Balsamo 1
Colle Di Val D'elsa 1
Corsico 1
Dallas 1
Duncan 1
Esslingen am Neckar 1
Falkenstein 1
Filottrano 1
Fuzhou 1
Groningen 1
Hyderabad 1
Los Angeles 1
Massarosa 1
Mcallen 1
Misano Adriatico 1
Montréal 1
Munich 1
Nagold 1
Old Bridge 1
Rimini 1
Rome 1
Rotterdam 1
Salerno 1
San Jose 1
Sassoferrato 1
Torino 1
Washington 1
Zhengzhou 1
Totale 3.395
Nome #
Searching for a common mechanism for placenta mediated pregnancy complications and cardiovascular disease: role of Lipoprotein (a) 297
Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion 235
Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment 190
Metabolomics by Nuclear Magnetic Resonance identifies patients with high risk of death within two years after a cardiovascular event: The case of the amiflorence II study 149
Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. 117
Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system 115
Different NT-proBNP circulating levels for different types of cardiac amyloidosis 113
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 111
The platypnea-orthodeoxia syndrome: an unusual case of dyspnea 100
Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism. 98
Risk of reoperation in bioprosthetic valve patients with indication for long-term anticoagulation. Results from the observational retrospective multicentre PLECTRUM study 97
High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI 88
Direct oral anticoagulants in the early phase of non-valvular atrial fibrillation-related ischemic stroke in very old patients undergoing systemic thrombolysis and/or mechanical thrombectomy 85
Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention. 83
Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years 83
Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. 82
Different models for oral anticoagulation management may be applied provided that minimal assistance criteria are fulfilled: An italian experience 82
Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting 79
Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. 77
On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty 76
Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism 75
Non-traumatic splenic rupture on dual antiplatelet therapy with aspirin and ticagrelor after stenting for acute coronary syndrome 75
Sharing data of clinical trials 73
Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation 73
Retinal vein occlusions: a review for the internist 72
Central nervous system hemangiopericytoma with bone and lung metastases: a case report. 72
Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism 72
A case of persistent hiccup after laparoscopic cholecystectomy. 67
Residual perfusion defects in patients with pulmonary embolism are related to impaired fibrinolytic capacity 65
Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants 63
Risk of recurrence in patients with pulmonary embolism: Predictive role of D-dimer and of residual perfusion defects on lung scintigraphy. 61
The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant 61
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants 60
The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism. 59
The role of D-dimer testing in patients with suspected venous thromboembolism 58
On-treatment platelet reactivity: State of the art and perspectives 58
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study 57
Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population 56
Management of oral anticoagulation in very old patients with non valvular atrial fibrillation related acute ischemic stroke 55
Funzione piastrinica e rischio di eventi avversi in pazienti con arteriopatia periferica sottoposti a rivascolarizzazione percutanea (Platelet function and risk of adverse events in peripheral artery disease patients undergoing percutaneous revascularization). 51
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study 50
Hypokalemia-induced rhabdomyolysis. 48
Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion 44
Capitolo 38: Anomalie della fibrinolisi e trombosi 44
Confidence in the Use of Direct Oral Anticoagulants in the Acute Phase of Nonvalvular Atrial Fibrillation–Related Ischemic Stroke Over the Years: A Real-World Single-Center Study 40
The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience 40
Homocysteine plasma levels influence impaired fibrinolitic capacity but not in vitro cleavage of fibrin by exogenous plasmin in patients with Pulmonary Embolism 36
Hypofibrinolysis accounts only in part for alteration of clot lysis time in patients with prior pulmonary embolism without pulmonary hypertension 33
[Stroke risk stratification in atrial fibrillation: oral anticoagulant therapy and bleeding risk in the elderly] 31
Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study 27
Poststroke Detection of Subclinical Paroxysmal Atrial Fibrillation in Patients With Embolic Stroke of Undetermined Source in the Real World Practice: The Empoli ESUS Atrial Fibrillation (E2AF) Study 26
Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin k antagonists: Results of epica study on the behalf of FCSA (italian federation of anticoagulation clinics) 26
Interleukin-6 as prognosticator in patients with COVID-19 20
Interleukin-6 added to CALL score better predicts the prognosis of COVID-19 patients 19
Prognostic determinants in patients with non traumatic intracerebral hemorrhage: a real life report 17
Predictive Factors for Hemorrhagic Transformation in Acute Ischemic Stroke in the REAL-World Clinical Practice 15
Totale 4.156
Categoria #
all - tutte 13.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020971 81 52 29 70 113 116 128 115 109 66 65 27
2020/2021639 41 43 56 87 32 74 47 40 68 80 34 37
2021/2022374 13 25 34 9 5 27 10 24 14 29 73 111
2022/2023936 99 226 40 63 44 164 132 49 78 4 25 12
2023/2024315 11 36 56 15 24 41 16 69 8 4 24 11
2024/202534 34 0 0 0 0 0 0 0 0 0 0 0
Totale 4.156